Novartis bets on experimental cancer treatment from US firm
Keystone / Georgios Kefalas
The Swiss pharma giant has made an offer to buy the rights to a tumor inhibiting treatment from Clovis Oncology in Colorado, which has filed for bankruptcy protection.
This content was published on
1 minute
Keystone-SDA/ac
Português
pt
Novartis aposta em tratamento experimental do câncer de empresa americana
Novartis has committed to pay $50 million (just under CHF47 million) upfront for all rights to the experimental cancer treatment. In addition, the Basel-based company has agreed to pay out up to an additional $333.75 million upon the successful reaching of development and regulatory milestones and $297 million in later sales milestones.
The experimental treatment and imaging agent known as FAP-2286 is in a phase I/II study, called Lumière, for its ability to bind to a fibroblast activating protein (FAP), Clovis said in a statement on Monday. It is the first peptide-targeted radionuclide therapy (PTRT) and imaging agent targeting FAP to enter clinical development.
The acquisition by Novartis is what is known as a “stalking horse purchase”. Clovis intends to submit the Novartis offer to other potential buyers in the hope of attracting competing proposals. These will be reviewed with advisers in a proceeding supervised by the U.S. Bankruptcy Court for the District of Delaware.
Popular Stories
More
Multinational companies
Azeri fossil-fuel cash cow brings controversy to Switzerland
Swiss-EU negotiations: Cassis to meet Sefcovic in Bern
This content was published on
Swiss Foreign Minister Ignazio Cassis will meet the Vice-President of the EU Commission, Maros Sefcovic, in Bern on Wednesday.
Heavy snowfall in Switzerland causes traffic chaos and accidents
This content was published on
The heavy snowfall late on Thursday and during the night into Friday led to traffic chaos and many accidents in many regions of Switzerland.
Chimpanzee behaviours passed down through generations
This content was published on
Some of the complex behaviours of chimpanzees have been passed down and refined over generations. These include the combination of several tools for foraging.
More than 600,000 rounds of Swiss sniper ammunition reach Ukraine
This content was published on
Sniper ammunition from Swiss P Defence reached Ukraine via a Polish company in July 2023, reported SRF Investigativ on Thursday, citing official information.
Switzerland launches national digital inclusion alliance
This content was published on
The Swiss government launched the Swiss Digital Inclusion Alliance on Thursday with the goal of giving as many people as possible access to digital services.
Swiss court recognises obesity as a disability under certain conditions
This content was published on
People suffering from obesity are now entitled to social benefits under certain conditions, following a ruling by the Federal Court.
Environment minister outlines Swiss efforts to limit global warming
This content was published on
Switzerland will do its part to achieve the goal of limiting global warming to 1.5 degrees Celcius, said Environment Minister Albert Rösti, who's attending COP29 in Baku.
This content was published on
Switzerland remains by a large margin the European champion of train travel, both in terms of the number of journeys per person and the number of kilometres travelled. Switzerland remains by a large margin the European champion of train travel, both in terms of the number of journeys per person and the number of kilometres travelled. Switzerland remains by a large margin the European champion of train travel, both in terms of the number of journeys per person and the number of kilometres travelled.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.